Role of angiotensin II in cardiovascular disease—therapeutic implications of more than a century of research

CM Ferrario - Journal of the Renin-angiotensin-aldosterone …, 2006 - journals.sagepub.com
More than a century of research on the renin-angiotensin system (RAS) has uncovered the
widespread involvement of angiotensin II (Ang II) in the pathophysiology of cardiovascular …

Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure

A Kazory - The American journal of cardiology, 2010 - Elsevier
The nonosmotic release of arginine vasopressin, concurrent with the activation of the
sympathetic nervous system and renin-angiotensin-aldosterone system, is thought to …

Cardiac-specific overexpression of AT1 receptor mutant lacking Gαq/Gαi coupling causes hypertrophy and bradycardia in transgenic mice

P Zhai, M Yamamoto, J Galeotti, J Liu… - The Journal of …, 2005 - Am Soc Clin Investig
Ang II type 1 (AT1) receptors activate both conventional heterotrimeric G protein–dependent
and unconventional G protein–independent mechanisms. We investigated how these …

Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension

R Fogari, A Mugellini, A Zoppi, G Marasi… - European Journal of …, 2004 - Springer
Objective This prospective, randomised, open-label, blinded-endpoint study was to compare
the effects of the angiotensin II (Ang II) AT1 receptor antagonist valsartan with those of the …

Epithelial-mesenchymal transitions and hepatocarcinogenesis

J Jou, AM Diehl - The Journal of clinical investigation, 2010 - Am Soc Clin Investig
Epithelial-mesenchymal transitions (EMTs) are believed to play a role in invasion and
metastasis of many types of tumors. In this issue of the JCI, Chen et al. show that a gene that …

Angiotensin-(1–9) in hypertension

I Norambuena-Soto, C Lopez-Crisosto… - Biochemical …, 2022 - Elsevier
Abstract Angiotensin-(1–9)[Ang-(1–9)] is a peptide of the non-canonical renin-angiotensin
system (RAS) synthesized from angiotensin I by the monopeptidase angiotensin-converting …

A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases

C Borghi, S Bacchelli, D Degli Esposti… - Expert Opinion on …, 2004 - Taylor & Francis
Based on preclinical and clinical findings, zofenopril appears to be an angiotensin-
converting enzyme (ACE) inhibitor with high potency, significant tissue selectivity and a long …

Microwave-enhanced copper-catalyzed N-arylation of free and protected amino acids in water

S Röttger, PJR Sjöberg, M Larhed - Journal of combinatorial …, 2007 - ACS Publications
A microwave-enhanced copper-catalyzed protocol for N-arylation using water as the solvent
is reported. This fast transformation allows the reaction between various amino acids or …

Interaction between serum cholesterol levels and the renin–angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure

C Borghi, M Veronesi, E Cosentino… - Journal of …, 2007 - journals.lww.com
Objectives To investigate the possible interactions between serum cholesterol levels and the
renin–angiotensin system on the development of stable hypertension in subjects with high …

Long-term clinical experience with zofenopril

C Borghi, S Bacchelli… - Expert review of …, 2012 - Taylor & Francis
Angiotensin-converting enzyme inhibitors are extensively used to improve clinical outcome
of patients with several cardiovascular diseases. Zofenopril proved to be very effective in …